What We're Reading: Page 270
Industry reads hand-picked by our editors
Dec 18, 2017
Dec 15, 2017
-
Stat
In wake of #MeToo, a new spotlight on harassment in biomedical science
-
Financial Times
Pharma industry’s return on R&D investment falls sharply
-
Forbes
This startup has a new CRISPR enzyme -- and says it will give it away for free
-
Chicago Tribune
Whistleblower says she warned drugmaker of risks of taking antipsychotic Seroquel with methadone
Dec 14, 2017
Dec 13, 2017
-
Politico
Why a drug for aging would challenge Washington
-
Chemical & Engineering News
CRISPR gene editing is coming to the clinic
-
Fortune
Why American entrepreneurs need to study China’s biotech strategy
Dec 12, 2017
Dec 11, 2017
Dec 08, 2017
-
Kaiser Health News
Cities, counties and schools sidestep FDA Canadian drug crackdown, saving millions
-
Bloomberg
Charity delays giving new aid after U.S. faults pharma ties
-
Genetic Engineering & Biotechnology News
Improvements to gene therapy clinical trial design benefit hemophilia patients
-
Los Angeles Times
FDA's program to speed up drug approval shaved nearly a year off the process